Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-12 11:46 am Unchanged | 13G | Capricor Therapeutics, Inc. CAPR | BlackRock Inc. BLK | 1,750,007 5.400% | 0 (Unchanged) | View |
2024-11-08 09:00 am Unchanged | 13G | Capricor Therapeutics, Inc. CAPR | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,789,699 6.500% | 0 (Unchanged) | View |
2024-10-24 2:02 pm Purchase | 13G | Capricor Therapeutics, Inc. CAPR | BlackRock Inc. BLK | 1,750,007 5.400% | 1,750,007 (New Position) | View |
2024-09-24 4:03 pm Purchase | 13G | Capricor Therapeutics, Inc. CAPR | Nippon Shinyaku Co Ltd | 7,090,351 18.900% | 2,798,507 (+65.21%) | View |
2024-08-23 4:01 pm Purchase | 13G | Capricor Therapeutics, Inc. CAPR | Nippon Shinyaku Co Ltd | 4,291,844 13.200% | 2,145,922 (+100.00%) | View |
2024-02-07 3:01 pm Purchase | 13G | Capricor Therapeutics, Inc. CAPR | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,789,699 9.100% | 2,789,699 (New Position) | View |
2023-10-17 4:05 pm Purchase | 13G | Capricor Therapeutics, Inc. CAPR | Nippon Shinyaku Co Ltd | 2,145,922 6.970% | 2,145,922 (New Position) | View |
2021-08-03 4:28 pm Sale | 13G | Capricor Therapeutics, Inc. CAPR | FEINBERG LARRY N | 0 0.000% | -2,000,000 (Position Closed) | View |
2021-02-08 4:30 pm Purchase | 13G | Capricor Therapeutics, Inc. CAPR | FEINBERG LARRY N | 2,000,000 9.780% | 2,000,000 (New Position) | View |